Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incretin therapy for diabetes mellitus type 2
Jens J. Holst
Current Opinion in Endocrinology Diabetes and Obesity (2019) Vol. 27, Iss. 1, pp. 2-10
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Food Polyphenols and Type II Diabetes Mellitus: Pharmacology and Mechanisms
Rabia Naz, Fatima Saqib, Samir Awadallah, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 3996-3996
Open Access | Times Cited: 67
Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk
José Marcos Sanches, Li Na Zhao, Albert Salehi, et al.
FEBS Journal (2021) Vol. 290, Iss. 3, pp. 620-648
Open Access | Times Cited: 70
Labeling and Characterization of Human GLP-1-Secreting L-cells in Primary Ileal Organoid Culture
Deborah A. Goldspink, Van B. Lu, Emily L. Miedzybrodzka, et al.
Cell Reports (2020) Vol. 31, Iss. 13, pp. 107833-107833
Open Access | Times Cited: 67
Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches
Geke Aline Boer, Jens J. Holst
Biology (2020) Vol. 9, Iss. 12, pp. 473-473
Open Access | Times Cited: 66
Characterization of on-target adverse events caused by TRK inhibitor therapy
D. Liu, James Flory, Andrew Lin, et al.
Annals of Oncology (2020) Vol. 31, Iss. 9, pp. 1207-1215
Open Access | Times Cited: 64
Tirzepatide: a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) dual agonist in development for the treatment of type 2 diabetes
Juan P. Frías
Expert Review of Endocrinology & Metabolism (2020) Vol. 15, Iss. 6, pp. 379-394
Closed Access | Times Cited: 51
Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test
Kieren J. Mather, Andrea Mari, Tim Heise, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 12, pp. 3046-3054
Open Access | Times Cited: 5
Incretin Hormones and Type 2 Diabetes – Mechanistic Insights and Therapeutic Approaches
Geke Aline Boer, Jens J. Holst
(2020)
Open Access | Times Cited: 33
Effects of glucagon‐like peptide‐1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study
Hitoshi Kuwata, Daisuke Yabe, Kenta Murotani, et al.
Journal of Diabetes Investigation (2021) Vol. 12, Iss. 12, pp. 2162-2171
Open Access | Times Cited: 30
Exendin-4 affects calcium signalling predominantly during activation and activity of beta cell networks in acute mouse pancreas tissue slices
Eva Paradiž Leitgeb, Jasmina Kerčmar, Lidija Križančić Bombek, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 3
Glucagonoma: From skin lesions to the neuroendocrine component (Review)
Florica Șandru, Mara Carşote, Simona Elena Albu, et al.
Experimental and Therapeutic Medicine (2020)
Open Access | Times Cited: 24
Induced Human Regulatory T Cells Express the Glucagon-like Peptide-1 Receptor
Anna K. O. Rode, Terkild B. Buus, Veronika Mraz, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2587-2587
Open Access | Times Cited: 16
Incretin based therapies and SGLT-2 inhibitors in kidney transplant recipients with diabetes: A systematic review and meta-analysis
Dora Oikonomaki, Evangelia Dounousi, Anila Duni, et al.
Diabetes Research and Clinical Practice (2020) Vol. 172, pp. 108604-108604
Closed Access | Times Cited: 19
Clinical Impact of Glucagon-Like Peptide-1 Receptor Analogs on the Complications of Obesity
Dilek Yazıcı, Hale Yapıcı Eser, Sinem Kıyıcı, et al.
Obesity Facts (2022) Vol. 16, Iss. 2, pp. 149-163
Open Access | Times Cited: 12
An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes - an Asian perspective
Yoshifumi Saisho
Expert Opinion on Pharmacotherapy (2020) Vol. 21, Iss. 13, pp. 1565-1577
Open Access | Times Cited: 15
Diabetes-Related Mechanisms of Action Involved in the Therapeutic Effect of Croton Species: A Systematic Review
Fernanda Espinoza-Hernández, Angelina Daniela Moreno-Vargas, Adolfo Andrade‐Cetto
Plants (2023) Vol. 12, Iss. 10, pp. 2014-2014
Open Access | Times Cited: 5
Modifying a Hydroxyl Patch in Glucagon-like Peptide 1 Produces Biased Agonists with Unique Signaling Profiles
Peiqi Wang, Timothy A. Hill, Justin M. Mitchell, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 17, pp. 11759-11775
Closed Access | Times Cited: 7
A comprehensive review on the antidiabetic attributes of thiazolidine‐4‐ones: Synthetic strategies and structure–activity relationships
Tathagata Pradhan, Ojasvi Gupta, Vivek Kumar, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 2
Closed Access | Times Cited: 7
Novel GLP-1 analog supaglutide improves glucose homeostasis in diabetic monkeys
Qiaoli Cui, Yijing Liao, Yaojing Jiang, et al.
Journal of Endocrinology (2020) Vol. 248, Iss. 2, pp. 145-154
Open Access | Times Cited: 5
GRK Inhibition Potentiates Glucagon-Like Peptide-1 Action
Seunghun P. Lee, Jenson Qi, Guozhang Xu, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 4
Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, double-blind, placebo-controlled, investigator-initiated study
M. Sørum, Anne Ortved Gang, Dorte Tholstrup, et al.
BMJ Open (2024) Vol. 14, Iss. 10, pp. e089862-e089862
Open Access
Metformin and sitagliptin fixed combination as the optimal choice in solving current problems in the type 2 diabetes mellitus treatment
Elena V. Biryukova, D. V. Kileynikov
Meditsinskiy sovet = Medical Council (2023) Vol. 17, Iss. 9, pp. 23-30
Open Access | Times Cited: 1
Epigenetic modifications at DMRs of imprinting genes in sperm of type 2 diabetic men
Maryam Jazayeri, Poopak Eftekhari‐Yazdi, Mohammad Ali Sadighi Gilani, et al.
Zygote (2022) Vol. 30, Iss. 5, pp. 638-647
Closed Access | Times Cited: 2
Kontrol Glikemik terhadap Kadar Profil Lipid pada Pasien DM Tipe 2
Wuni Sri Lestari, Eka Fitriana, Witi Karwiti, et al.
Journal of Telenursing (JOTING) (2023) Vol. 5, Iss. 2, pp. 3215-3222
Open Access
Glp-1 Analogs for the Treatment of Obesity and Diabetes
Juan Belloni, X Tapper
Endocrinology and Disorders (2022) Vol. 6, Iss. 2, pp. 01-06
Open Access
Page 1 - Next Page

Scroll to top